Recombinant DNA Technology

Recombinant DNA technology (RDT) involves combining DNA from different organisms to create new genetic combinations, often used to create organisms with improved or novel characteristics. This field fundamentally changed biotechnology.

1. Making recombinant DNA molecules: This process involves isolating specific DNA fragments from a donor organism and inserting them into a vector molecule (like a plasmid) to create a new DNA molecule. This new molecule, containing DNA from two different sources, is what we call recombinant DNA.
2. Using cloning and expression vectors: Vectors are essential tools for RDT. Cloning vectors are DNA molecules (typically plasmids or viruses) that can self-replicate in a host cell and are used to carry and make multiple copies of a foreign DNA fragment. Expression vectors are a type of cloning vector designed not only to propagate the DNA but also to ensure the transcription and translation of the inserted gene into a protein product within the host cell.
3. The ampicillin/X-gal double-selection assay: This is a common and highly effective method used to identify bacterial cells that have successfully taken up recombinant plasmids. It relies on both antibiotic resistance and a colorimetric assay to differentiate between cells containing the original vector, those with the recombinant vector, and those with no vector at all.
4. Applications of recombinant DNA technology: RDT has revolutionized many fields. Its applications include:
   • Gene cloning: Producing multiple identical copies of a specific gene.
   • Gene therapy: Introducing functional genes into cells to replace or inactivate mutated genes that cause disease.
   • Production of genetically modified organisms (GMOs): Creating plants, animals, or microorganisms with desired traits (e.g., disease resistance, enhanced nutritional value, increased yield).
   • Production of therapeutic proteins: Manufacturing insulin, human growth hormone, vaccines, and other pharmaceuticals.

Forensic DNA Profiling

Forensic DNA profiling, also known as DNA fingerprinting or DNA typing, is a powerful technique used for identification based on unique patterns in an individual's DNA.

1. RFLP (Restriction Fragment Length Polymorphism): This older method analyzes variations in the lengths of DNA fragments produced after digestion with specific restriction enzymes. Because individuals have different DNA sequences, the restriction enzyme cuts occur at different locations, leading to fragments of varying sizes. These fragments are then separated by gel electrophoresis, creating a unique banding pattern. While highly discriminatory, RFLP requires a relatively large amount of intact DNA and is more time-consuming than modern methods.
2. STR loci (Short Tandem Repeats): STRs are short sequences of DNA (typically 2-6 base pairs long) that are repeated multiple times in a head-to-tail manner at specific locations (loci) on chromosomes. The number of repeats at each locus varies significantly among individuals, making them highly polymorphic and invaluable for personal identification. This variation is the basis of modern forensic DNA fingerprinting.
3. DNA fingerprints: These are unique profiles generated from DNA evidence that serve as a genetic identifier for individuals. By analyzing multiple STR loci, a highly specific profile can be created that is statistically unique to an individual (with the exception of identical twins). These profiles are compared to samples from crime scenes, suspects, or reference samples for identification.
4. Mitochondrial DNA forensics: This technique utilizes DNA found in mitochondria, which is inherited exclusively from the mother (maternally inherited). Unlike nuclear DNA, each cell contains hundreds to thousands of mitochondria, meaning there are many copies of mtDNA. This makes it particularly useful in cases where nuclear DNA is scarce or degraded (e.g., ancient remains, highly damaged samples like burned bone or hair shafts without follicles). It's used for identification when a maternal lineage can be traced.

Creating Recombinant DNA Molecules

The creation of a recombinant DNA molecule is a multi-step process:

• Digestion with restriction enzymes (e.g., HindIII): Restriction enzymes, also known as molecular scissors, are naturally occurring bacterial enzymes that recognize and cut DNA at specific, short nucleotide sequences called restriction sites. These sites are often palindromic. Some enzymes, like HindIII, make staggered cuts, producing DNA fragments with single-stranded overhangs called sticky ends. These sticky ends are crucial because they can readily base-pair with complementary sticky ends on other DNA fragments that have been cut with the same enzyme. Other enzymes produce blunt ends, which are less efficient for ligation but can be joined to any other blunt end.
• Ligation: After the foreign DNA and the vector DNA have been cut with the same restriction enzyme, they are mixed. Their complementary sticky ends anneal (base-pair) to each other. The enzyme DNA ligase is then added. DNA ligase repairs the phosphodiester backbone of the DNA strands by forming new phosphodiester bonds, effectively sealing the nicks and covalently joining the foreign DNA fragment into the vector. This forms a stable recombinant DNA molecule.
• Recombinant DNA ligase: This refers to the process where DNA ligase facilitates the joining of DNA fragments, particularly those cleaved by restriction enzymes, to form a recombinant molecule. The efficiency of ligation is significantly enhanced when fragments possess complementary sticky ends generated by the same restriction enzyme.

Cloning Vectors

Definition

A cloning vector is a small piece of DNA (usually a plasmid or a virus) that can be stably maintained and replicated in a host organism, into which a foreign DNA fragment can be inserted for cloning purposes. Its primary function is to carry and maintain the gene of interest so that multiple identical copies can be made.

Components of the pUC18 cloning vector

The pUC18 plasmid is a widely used and well-characterized cloning vector with several key features:

1. $\text{amp}^{\text{R}}$ (Ampicillin resistance gene): This gene encodes an enzyme, $\beta$-lactamase, which inactivates the antibiotic ampicillin. Its presence allows for positive selection of bacterial cells that have successfully taken up the plasmid. Only bacteria containing the pUC18 plasmid (and thus the $\text{amp}^{\text{R}}$ gene) will be able to grow and form colonies on a culture medium containing ampicillin.
2. lacZ+ gene: This gene codes for the N-terminal fragment of $\beta$-galactosidase, an enzyme that normally breaks down lactose. In the context of cloning, it's used for blue-white screening. When this gene is intact and expressed, bacterial colonies grown on a medium containing X-gal (a colorless chromogenic substrate) will turn blue, because $\beta$-galactosidase cleaves X-gal to produce a blue product.
3. Polylinker region (Multiple Cloning Site - MCS): This is a synthetic DNA sequence located within the lacZ+ gene. It contains a cluster of recognition sites for many different restriction enzymes, allowing for flexibility in choosing the appropriate enzyme to insert foreign DNA. The presence of multiple unique restriction sites makes it easy to insert a DNA fragment without disrupting other essential plasmid functions.
4. Disruption of lacZ+: The key to blue-white screening is that inserting foreign DNA into one of the restriction sites within the polylinker region will disrupt the coding sequence of the lacZ+ gene. This interruption prevents the production of a functional $\beta$-galactosidase enzyme. As a result, bacterial cells containing a recombinant plasmid (with an insert) will not be able to cleave X-gal, leading to white colonies. This allows for easy visual differentiation between bacteria carrying the original plasmid (blue colonies) and those carrying the recombinant plasmid (white colonies).

Process of Using Cloning Vector pUC18

The process of creating and selecting bacteria with recombinant pUC18 plasmids typically involves these steps:

1. Incubation with restriction enzyme EcoR1: The circular pUC18 plasmid is incubated with a specific restriction enzyme, such as EcoR1. EcoR1 recognizes a specific sequence within the polylinker region of pUC18 and makes a precise cut, linearizing the plasmid and creating compatible sticky ends (in this case, GATC overhangs) that are ready to accept foreign DNA.
2. Treatment of foreign DNA: Concurrently, the DNA fragment of interest (the 'foreign DNA') is isolated and also treated with the same restriction enzyme, EcoR1. This ensures that the foreign DNA fragment also has complementary sticky ends, allowing it to precisely anneal with the linearized pUC18 plasmid.
3. Mixing the DNA: The linearized pUC18 plasmid and the cut foreign DNA fragments are then mixed together in the presence of DNA ligase. The complementary sticky ends base-pair, and DNA ligase catalyzes the formation of phosphodiester bonds, covalently joining the foreign DNA into the plasmid. This crucial step results in the formation of a recombinant plasmid, which now contains the foreign DNA insert within the lacZ+ gene, thereby disrupting it.
4. Introduction into bacteria by transfection (or transformation): The recombinant plasmids are then introduced into competent bacterial cells, typically E. coli, a process called transformation (for bacterial cells). Competence refers to the bacterial cell's ability to take up foreign extracellular DNA. This is often achieved by treating cells with calcium chloride and heat shock, or by electroporation. Once inside the host bacteria, these plasmids are replicated along with the bacterial chromosome, producing many copies of the recombinant DNA.

Antibiotic/Blue-White Double-Selection Assay

This powerful screening method allows researchers to identify bacterial cells carrying the desired recombinant plasmid rather than the original plasmid or no plasmid at all.

Antibiotic Selection

• Only bacteria containing the $\text{amp}^{\text{R}}$ gene can survive in an ampicillin-containing medium: When bacterial cells are grown on an agar plate supplemented with the antibiotic ampicillin, only those cells that have successfully taken up a plasmid containing the $\text{amp}^{\text{R}}$ gene (like pUC18, whether it's recombinant or not) will be able to detoxify ampicillin and survive. Bacteria that did not take up any plasmid will be killed by the ampicillin.
• Ampicillin resistant cells: These are the only bacteria that will reproduce and form colonies in the presence of the antibiotic, thus selecting for cells that have been successfully transformed with a plasmid.

X-gal Selection

• $\beta$-galactosidase Activity: This component relies on the lacZ+ gene within the pUC18 plasmid. If the lacZ+ gene is intact (i.e., no foreign DNA has been inserted into its polylinker site), the $\beta$-galactosidase enzyme it codes for will be produced. This enzyme can then cleave the colorless substrate X-gal (5-bromo-4-chloro-3-indolyl-$\beta$-D-galactopyranoside) present in the growth medium, producing a blue colored insoluble precipitate.
• E. coli background: The host bacterium used in this assay is specifically engineered to be lacZ- (lacking its own functional $\beta$-galactosidase gene). This means that to produce a functional $\beta$-galactosidase enzyme and, consequently, a blue color, the E. coli cell must have received the lacZ+ gene from the pUC18 plasmid.

Results of Selection

By combining antibiotic selection and blue-white screening, three types of outcomes can be differentiated on an ampicillin/X-gal agar plate:

1. White colonies: These colonies represent bacteria that have successfully taken up a recombinant plasmid. The foreign DNA insert has disrupted the lacZ+ gene, preventing the production of functional $\beta$-galactosidase. Therefore, these bacteria cannot cleave X-gal and remain white. These are the colonies of interest, containing your cloned gene.
2. Blue colonies: These colonies represent bacteria that have taken up the original pUC18 plasmid (often referred to as a non-recombinant or 'empty' vector). The lacZ+ gene is intact and functional, leading to the production of $\beta$-galactosidase, which cleaves X-gal to produce a blue color. These are not the desired clones.
3. Bacteria without a plasmid: These cells will not grow at all on media containing ampicillin. Since they lack the $\text{amp}^{\text{R}}$ gene, they are susceptible to the antibiotic and are killed, thus not forming any colonies.

Genetic Engineering in Plants

Genetic engineering in plants often relies on exploiting natural mechanisms of DNA transfer.

Agrobacterium Ti Plasmid

• Function: The soil bacterium Agrobacterium tumefaciens is a natural plant pathogen that causes crown gall disease. It has a large plasmid called the Ti (tumor-inducing) plasmid. This natural ability to transfer DNA has been harnessed for genetic engineering. Scientists modify the Ti plasmid by removing its tumor-inducing genes and inserting desired foreign genes, making it a powerful vector to introduce foreign genes into plant cells.
• Segments TL and TR (T-DNA borders): The actual segment of the Ti plasmid that is transferred from the bacterium to the plant cell's nucleus and integrated into the plant genome is called the T-DNA (transfer DNA). This T-DNA is precisely defined by two short, imperfect direct repeat sequences known as the left border (TL) and right border (TR) sequences. These border sequences are crucial for the recognition and transfer machinery of Agrobacterium. The genes flanked by TL and TR are the ones that will be transferred.
• Integration into Plant DNA: Once transferred into the plant cell, the single-stranded T-DNA is guided to the nucleus, where it is converted to a double-stranded form and then randomly integrated into one of the plant cell's chromosomes. This stable integration ensures that the foreign genes are passed on to all daughter cells and, ultimately, to the whole plant. The process is mediated by virulence (Vir) genes encoded elsewhere on the Ti plasmid or bacterial chromosome.

Transgenic Crops

Transgenic crops are plants that have had their genetic makeup modified through genetic engineering techniques to introduce new desirable traits from other organisms.

Example: Glyphosate Resistance

• EPSP synthase: This enzyme (5-enolpyruvylshikimate-3-phosphate synthase) is a critical enzyme in the shikimate pathway, which is essential for the biosynthesis of aromatic amino acids in plants and microorganisms. Animals do not possess this pathway. Glyphosate, a widely used broad-spectrum herbicide, specifically targets and inhibits EPSP synthase, effectively killing plants by preventing the synthesis of these essential amino acids.
• Molecular Strategy: To develop glyphosate-resistant crops (e.g., Roundup Ready crops), a modified version of the EPSP synthase gene (often from a glyphosate-resistant bacterium) is introduced into the plant genome using the Agrobacterium Ti plasmid system. This modified transgene is placed under the control of a strong, constitutive viral promoter (e.g., from the cauliflower mosaic virus, CaMV 35S promoter). This promoter ensures that the plant expresses very high levels of the bacterial EPSP synthase enzyme, which is less sensitive to glyphosate. Even in the presence of glyphosate, the plant can still produce sufficient amounts of aromatic amino acids using the resistant enzyme, allowing it to survive and thrive while weeds are killed.

Gene Targeting and Knockout Mice

Gene targeting is a genetic engineering technique that uses homologous recombination to alter a specific gene within a cell, often to create knockout mice – mice in which a specific gene has been inactivated or "knocked out". These models are invaluable for studying gene function and human diseases.

Creation of Knockout Mice

• Homologous Recombination: This technique is central to gene targeting. It relies on the cell's natural DNA repair mechanism where segments of DNA with similar sequences can exchange genetic material. In gene targeting, a specially designed targeting vector (a DNA construct containing homologous sequences to the target gene, along with a positive selectable marker like the neomycin resistance gene) is introduced into embryonic stem (ES) cells. If successful, the targeting vector will replace a portion of the endogenous gene with the resistance gene, thereby disrupting the gene's function and creating a null mutant.
• Thymidine Kinase Gene (tk): This gene from the herpes simplex virus (HSV-tk) is utilized for negative selection to get rid of cells where the plasmid integrated randomly rather than by homologous recombination. The HSV-tk gene makes cells sensitive to the antiviral drug ganciclovir. Cells that undergo random integration often retain the HSV-tk gene (which is usually placed outside the regions of homology in the targeting vector), making them susceptible to ganciclovir and thus eliminated. Cells that undergo correct homologous recombination lose the HSV-tk gene (as it's outside the exchanged region) and survive ganciclovir treatment.
• Two possible outcomes in ES cells:
  1. The gene of interest is knocked out, and the target gene is replaced: This is the desired outcome. The targeting vector specifically exchanges with the homologous genomic region, inserting the neomycin resistance gene (thus inactivating the target gene) and simultaneously eliminating the HSV-tk gene at the ends of the vector. These cells are selected by growing them in a medium containing neomycin (to select for integration) and ganciclovir (to select against random integration).
  2. The plasmid integrates randomly without knocking out the target gene: In this scenario, the entire targeting vector integrates into a random location in the genome, not where the target gene is. These cells will be resistant to neomycin (because they took up the plasmid) but will also retain the HSV-tk gene, making them sensitive to ganciclovir. Consequently, they will die in the selection medium. This dual selection process significantly enriches for correctly targeted ES cells.

Gene Therapy and MLV

Gene therapy aims to treat or prevent disease by replacing, inactivating, or introducing genes into a patient's cells. Retroviruses, like MLV, have been extensively studied as vectors for gene delivery.

Gene Therapy using MLV (Murine Leukemia Virus)

• MLV Virus: The Murine Leukemia Virus (MLV) is a retrovirus that has been engineered for gene therapy applications, particularly for diseases like Severe Combined Immunodeficiency (SCID). Retroviruses are advantageous because they integrate their genetic material stably into the host cell's genome, ensuring long-term expression of the therapeutic gene. For safety, gene therapy vectors derived from MLV are made replication-defective by removing the viral genes necessary for replication (e.g., gag, pol, env), ensuring they can only infect cells once and cannot spread throughout the body. Packaging cells provide the missing viral functions in trans.
• Components of an engineered MLV vector: An engineered MLV vector typically includes:
  • A therapeutic gene: For SCID, this would be the human ADA (Adenosine Deaminase) gene, which is missing or defective in patients.
  • A neomycin resistance gene: Used as a selectable marker in ex vivo gene therapy, allowing for the selection and expansion of patient cells (e.g., hematopoietic stem cells) that have successfully incorporated the vector.
  • Strong promoters: Sequences like the long terminal repeats (LTRs) of the retrovirus or other strong viral promoters (e.g., CMV promoter) are used to drive high levels of expression of the therapeutic gene in the target cells.
  • A payload for correction of the genetic defect: The entire construct is designed to deliver and express the functional gene that can correct the underlying genetic cause of the disease. In SCID, functional ADA enzyme restores immune function.

Forensic DNA Profiling Techniques

RFLP and STR Analysis

1. RFLP: As discussed earlier, RFLP analyzes fragment length variations. After digesting DNA with restriction enzymes, the fragments are separated by agarose gel electrophoresis, transferred to a membrane via Southern blotting, and then visualized using DNA probes that hybridize to specific polymorphic regions. While historically significant, RFLP requires large, undegraded DNA samples and is labor-intensive, making it less common for routine forensic analysis today.
2. STRs: Short Tandem Repeats are the current gold standard in forensic DNA analysis. The process involves:
   • PCR (Polymerase Chain Reaction): Specific primers are used to amplify individual STR loci from even minute amounts of degraded DNA. Multiple STR loci are typically amplified simultaneously in a single reaction (multiplex PCR).
   • Capillary Electrophoresis: The amplified STR fragments are then separated by size using capillary electrophoresis, a high-resolution separation technique. A laser detects fluorescent tags on the primers, and the data is analyzed by specialized software, which generates a DNA profile showing the number of repeats at each locus.
   • Number of repeats varies per individual: The number of tandem repeats at each STR locus acts as an allele. By analyzing multiple unlinked STR loci, a highly discriminating and statistically unique DNA profile can be generated for an individual, making them useful for identity verification in forensic investigations.

CODIS

• The FBI utilizes a standardized set of 13 core STR markers in the Combined DNA Index System (CODIS). This system is a national DNA database that stores and compares DNA profiles from crime scene evidence, convicted offenders, and missing persons. Each profile in CODIS is a numerical representation of the allele sizes at these 13 specific STR loci. This standardized approach allows forensic laboratories across the United States (and internationally, where similar systems exist) to compare DNA profiles, helping to link crimes, identify suspects, and exonerate the innocent.

Examples of Forensic Identification

DNA profiling has been instrumental in numerous high-profile cases, demonstrating its power and reliability in forensic science.

1. 9/11 Victims: Due to the extreme heat and force of the attacks, many remains were severely fragmented and degraded, yielding little or no nuclear DNA suitable for standard STR analysis. However, mitochondrial DNA analysis (mtDNA) was extensively applied. Its higher copy number per cell and maternal inheritance pattern made it invaluable for identifying victims, even from highly compromised biological samples like fragmented bone and teeth, by comparing with reference samples from maternal relatives.
2. O.J. Simpson Case: The trial in the mid-1990s was one of the first high-profile criminal cases where DNA profiling evidence played a critical role in establishing connections between samples from the crime scenes, the defendant, and his vehicle. Although the nascent state of DNA technology at the time and issues with sample collection and handling complicated its interpretation, it brought forensic DNA analysis into public consciousness.
3. Anna Anderson Case: Mitochondrial DNA forensics was utilized decades after her death to conclusively dispute claims of identity in connection with the Romanov imperial family. Anna Anderson had long claimed to be Grand Duchess Anastasia Nikolaevna of Russia, who was supposedly executed with her family in 1918. By comparing mtDNA from Anna Anderson's tissues with known Romanov relatives, it was definitively shown that she was not related to the Romanovs, thus solving a historical mystery.